OncoSec Medical Inc (ONCSQ)

[Titan V]

Any smart company, and I bet Merck falls into the category, would not want to draw their competitors' attention to a collaboration they are undertaking that is aiming to increase the effectiveness of their lead immunotherapy drug. We all know how MDVN's final buyout price rose after Sanofi's bid became public knowledge. Sanofi did not end up with MDVN, Pfizer did, with the highest bid at $81.50 a share. There were other bids in between.

http://www.wsj.com/articles/pfizer-to-buy-medivation-for-14-billion-1471864168